US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist

19.850
-0.950-4.57%

Close Nov 29 13:00 ET

19.850
0.0000.00%

Post 17:01 ET

1.83BMarket Cap-8981P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NewAmsterdam Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 1.626M	--
--	2024/Q3	27.126M / 1.705M	--
--	2024/Q2	2.085M / 1.109M	--
--	2024/Q1	1.304M / 1.607M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 1.626M--

--2024/Q327.126M / 1.705M--

--2024/Q22.085M / 1.109M--

--2024/Q11.304M / 1.607M--

Unlock Free Earnings Estimates

Open Account

NewAmsterdam Pharma Earnings Reports

8-K: NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results

Nov 6 08:02 ET

10-Q: Quarterly report

Nov 6 08:02 ET

20-F/A: Registration statement / Annual report / Transition report (Amendment)

Oct 28 08:04 ET

10-Q: Q2 2024 Earnings Report

Aug 7 08:01 ET

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall